CD8A and myeloid sarcoma: Therefore, the immune dynamics of various subset of the CD8+ T cell recall in SARS-CoV-2 experienced MS-OCR and RA-MTX patients were elucidated (Figure 5a and Figure 5—figure supplement 1).